Harvard Bioscience Cash Flow - Quarterly (NASDAQ:HBIO)

Add to My Stocks
$4.85 $0.15 (3.19%) HBIO stock closing price Feb 21, 2018 (Closing)

The Harvard Bioscience cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Harvard Bioscience profits and Harvard Bioscience debt. This statement can tell if a company is running out of money while still being profitable and is useful in Harvard Bioscience stock analysis. Harvard Bioscience had a negative net income cash flow of $-1.86M till this quarter of 2017 Q3. This report is very useful in measuring the short term viability of a company. HBIO decrease in investments stood at a value of $-0.71M for the latest quarter 2017 Q3.

View and download details of Harvard Bioscience cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2.9M1.91M-4.36M3.35M2.24M1.09M4.65M3.36M
Net Increase (Decrease) in Assets Liabilities-1.64M-2.28M-1.32M-0.04M-0.47M-2.37M-1.98M-2.71M-3.49M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net2.6M1.68M-5.36M3.75M1.7M-17.8M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.67M-0.43M-0.19M-1.44M-0.92M-0.4M-0.2M-2.95M-2.29M
Acquisition Disposition of Subsidiaires---1.41M----4.54M-4.54M
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-0.03M-0.03M-0.03M-0.03M-0.03M-0.01M--0.01M-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-0.1M-0.07M-0.15M---0.01M-0.11M2.04M1.95M
Issuance (Repayment) of Debt Securities-1.25M-0.55M-0.11M-5.05M-3.73M-2.62M-1.61M5.8M-1.3M
Increase (Decrease) in Bank & Other Borrowings--------8.35M-
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities--------0.03M-0.03M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----1.6M-0.44M-0.28M--0.03M-0.76M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year6.74M14.13M25.77M20.68M17.91M19.7M16.58M13.69M18.2M
Cash & Equivalents at Year End5.83M4.72M4.59M5.59M5.34M3.63M4.17M6.74M6.09M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Harvard Bioscience stock comparison chart provides an easy way to compare the stock price with peers along with details of Harvard Bioscience stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Harvard Bioscience had a Net Change in Cash and Cash Equivalents of $- in the latest quarter 2017 Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Harvard Bioscience stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $1.99M for HBIO.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.71M for HBIO stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-1.35M for Harvard Bioscience.

Key Financial Ratios For Harvard Bioscience Cash Flow

FCF margin

Quarterly Cash Flow Statements For Harvard Bioscience, Inc. Peers

Agilent cash flow, Danaher cash flow, MTS Systems cash flow, Newport cash flow, PerkinElmer cash flow